Valeo
Short position disclosed on November 4, 2026.
Evolution of the disclosed total
October 14, 2014 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since | Filing |
|---|---|---|---|---|---|
| Kintbury Capital LLP | 2.42% | -0.05 pt | October 30, 2026 | ||
| Blackrock Investment Management (UK) Limited | 2.20% | +0.48 pt | November 4, 2026 | ||
| Marshall Wace LLP | 2.02% | -0.87 pt | November 3, 2026 | ||
| Citadel Advisors LLC | 1.72% | +0.54 pt | November 3, 2026 | ||
| Capital Fund Management | 1.24% | new | October 7, 2026 | ||
| Citadel Advisors Europe Limited | 1.21% | +0.05 pt | November 4, 2026 | ||
| D. E. Shaw & CO., L.P. | 0.90% | +0.36 pt | September 30, 2026 | ||
| Squarepoint OPS LLC | 0.60% | new | October 21, 2026 | ||
| Envestra Capital LLP | 0.54% | -0.04 pt | October 20, 2026 |
In the United States VLEEF (OTC): 828,421 shares sold short on October 15, 2026. FINRA names no fund.
On the other side: the funds that hold Valeo Titelia
Get the moves on Valeo by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures
| Date | Fund | % of capital | End of publication | Filing |
|---|---|---|---|---|
| November 7, 2024 | Qube Research & Technologies Limited | 1.36% | December 10, 2024 | |
| November 6, 2024 | Marshall Wace LLP | 2.82% | AMF | |
| November 6, 2024 | Qube Research & Technologies Limited | 1.53% | December 10, 2024 | |
| November 6, 2024 | Gladstone Capital Management LLP | 1.12% | January 17, 2025 | AMF |
| November 6, 2024 | Citadel Advisors Europe Limited | 0.81% | March 12, 2025 | |
| November 6, 2024 | Southpoint Capital Advisors LP | 0.67% | September 1, 2025 | |
| November 5, 2024 | Marshall Wace LLP | 2.71% | AMF | |
| November 4, 2024 | Millennium International Management LP | 0.87% | June 10, 2026 | |
| November 1, 2024 | Qube Research & Technologies Limited | 1.45% | December 10, 2024 | |
| November 1, 2024 | Citadel Advisors Europe Limited | 0.76% | March 12, 2025 | |
| October 31, 2024 | Marshall Wace LLP | 2.60% | AMF | |
| October 29, 2024 | Marshall Wace LLP | 2.53% | AMF | |
| October 29, 2024 | Qube Research & Technologies Limited | 1.54% | December 10, 2024 | |
| October 28, 2024 | Marshall Wace LLP | 2.47% | AMF | |
| October 28, 2024 | Qube Research & Technologies Limited | 1.34% | December 10, 2024 | |
| October 25, 2024 | Marshall Wace LLP | 2.39% | AMF | |
| October 25, 2024 | Qube Research & Technologies Limited | 1.24% | December 10, 2024 | |
| October 25, 2024 | Gladstone Capital Management LLP | 1.08% | January 17, 2025 | AMF |
| October 25, 2024 | Millennium International Management LP | 0.91% | June 10, 2026 | |
| October 25, 2024 | Citadel Advisors Europe Limited | 0.64% | March 12, 2025 | |
| October 24, 2024 | Millennium International Management LP | 1.16% | June 10, 2026 | |
| October 23, 2024 | Marshall Wace LLP | 2.20% | AMF | |
| October 21, 2024 | Marshall Wace LLP | 2.11% | AMF | |
| October 18, 2024 | Marshall Wace LLP | 2.07% | AMF | |
| October 18, 2024 | Millennium International Management LP | 1.27% | June 10, 2026 | |
| October 17, 2024 | Millennium International Management LP | 1.30% | June 10, 2026 | |
| October 17, 2024 | Qube Research & Technologies Limited | 0.98% | December 10, 2024 | |
| October 17, 2024 | Citadel Advisors LLC | 0.49% | October 21, 2024 | |
| October 15, 2024 | Marshall Wace LLP | 1.91% | AMF | |
| October 15, 2024 | Citadel Advisors LLC | 0.50% | October 21, 2024 | |
| October 15, 2024 | Envestra Capital LLP | 0.48% | October 17, 2024 | |
| October 14, 2024 | Qube Research & Technologies Limited | 1.09% | December 10, 2024 | |
| October 11, 2024 | Marshall Wace LLP | 1.81% | AMF | |
| October 11, 2024 | Kintbury Capital LLP | 1.64% | AMF | |
| October 11, 2024 | Millennium International Management LP | 1.23% | June 10, 2026 | |
| October 8, 2024 | Marshall Wace LLP | 1.71% | AMF | |
| October 8, 2024 | Envestra Capital LLP | 0.51% | October 17, 2024 | |
| October 7, 2024 | Millennium International Management LP | 1.14% | June 10, 2026 | |
| October 3, 2024 | Marshall Wace LLP | 1.62% | AMF | |
| October 3, 2024 | Qube Research & Technologies Limited | 1.10% | December 10, 2024 | |
| October 2, 2024 | Qube Research & Technologies Limited | 1.08% | December 10, 2024 | |
| September 30, 2024 | Marshall Wace LLP | 1.53% | AMF | |
| September 30, 2024 | Millennium International Management LP | 1.07% | June 10, 2026 | |
| September 30, 2024 | Citadel Advisors Europe Limited | 0.79% | March 12, 2025 | |
| September 27, 2024 | Millennium International Management LP | 1.12% | June 10, 2026 | |
| September 27, 2024 | Qube Research & Technologies Limited | 1.10% | December 10, 2024 | |
| September 27, 2024 | Citadel Advisors LLC | 0.46% | October 1, 2024 | |
| September 26, 2024 | Marshall Wace LLP | 1.40% | AMF | |
| September 26, 2024 | Gladstone Capital Management LLP | 0.98% | January 17, 2025 | AMF |
| September 26, 2024 | Qube Research & Technologies Limited | 0.87% | December 10, 2024 |
The AMF column opens the filing the fund itself lodged, on the regulator own site. Documents read for positions up to August 26, 2026.
Download 1,711 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in France
- Renault 11.51% of the capital sold short
- Viridien 10.26% of the capital sold short
- Ubisoft Entertainment 9.76% of the capital sold short
- FDJ United 6.73% of the capital sold short
- Alstom 5.94% of the capital sold short
- Abivax 5.69% of the capital sold short
- Teleperformance 5.45% of the capital sold short
- Gaztransport et Technigaz 4.88% of the capital sold short
- Atos Group 4.41% of the capital sold short
- Forvia 4.38% of the capital sold short
- Nexity 4.16% of the capital sold short
- Rémy Cointreau 4.05% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Valeo, source AMF, data as at November 4, 2026, https://www.quivad.com/action/valeo?page=16